Jason Najum
Jason Najum is a Senior Editor & Creative Producer at States of Mind with extensive experience in the psychedelic medicine space. He has held senior editorial roles at Psychedelics.com and Microdose Psychedelic Insights, and was a regular contributor to The Huffington Post. His work has also appeared in Seeking Alpha, National Geographic, and Lonely Planet.
Articles by Jason Najum
CBT Therapists on What Cognitive Behavioural Therapy Can Offer
Therapists explain how CBT builds clarity, emotional awareness, and skills for anxiety, depression, ADHD, and…
My Experience at a Legal Psilocybin Therapy Retreat
States of Mind's Senior Editor tells us what actually happens at a psychedelic therapy session.
I Went to The Netherlands For A Legal Psychedelic Therapy Retreat
States of Mind's Senior Editor experiences legal psilocybin therapy — the first part in a…
What Really Happens at a Men’s Retreat?
States of Mind speaks to a men's retreat founder for a glimpse into the emotional…
I Wasn't Sick, But I Wasn't Well: A Mental Health Story
States of Mind's senior editor shares his journey to overcome anxiety through mindfulness, microdosing, and…
Inside Europe’s First Residential Ketamine Therapy Retreat
A short flight from mainland Europe, people are traveling to Malta for retreat-style care and…
Unmasking ADHD: Samantha Hiew on Late Diagnosis and the Layers We Don’t See
Dr. Samantha Hiew shares her ADHD journey and advocacy to empower neurodivergent women
The Psychedelic DJ: How Matt Xavier is Turning Music into Medicine
The story of a DJ using music to enhance psychedelic therapy and help patients heal.
The Courage to Heal: A Conversation With Tom Feegel of Beond Ibogaine Treatment Center
“There’s usually a painful past, and sometimes we label that as trauma”.
The Fight for 7-OHM: Inside the Movement to Legitimize a Controversial New Plant Medicine
A new conversation (and controversy) is unfolding around 7-OHM in the world of plant medicine.
Ketamine for Mental Health: A Deep Look into Science-Based Treatment
Once an anesthetic, ketamine is now approved for treating resistant depression. How did it happen?